345 related articles for article (PubMed ID: 32993026)
1. PAI-1, the Plasminogen System, and Skeletal Muscle.
Rahman FA; Krause MP
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993026
[TBL] [Abstract][Full Text] [Related]
2. The plasminogen activation system in skeletal muscle regeneration: antagonistic roles of urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1).
Suelves M; Vidal B; Ruiz V; Baeza-Raja B; Diaz-Ramos A; Cuartas I; Lluis F; Parra M; Jardi M; Lopez-Alemany R; Serrano AL; Munoz-Canoves P
Front Biosci; 2005 Sep; 10():2978-85. PubMed ID: 15970552
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of plasminogen activator inhibitor-1 restores skeletal muscle regeneration in untreated type 1 diabetic mice.
Krause MP; Moradi J; Nissar AA; Riddell MC; Hawke TJ
Diabetes; 2011 Jul; 60(7):1964-72. PubMed ID: 21593201
[TBL] [Abstract][Full Text] [Related]
4. Mice deficient in plasminogen activator inhibitor-1 have improved skeletal muscle regeneration.
Koh TJ; Bryer SC; Pucci AM; Sisson TH
Am J Physiol Cell Physiol; 2005 Jul; 289(1):C217-23. PubMed ID: 15716324
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen Activator Inhibitor Type-1 as a Regulator of Fibrosis.
Rabieian R; Boshtam M; Zareei M; Kouhpayeh S; Masoudifar A; Mirzaei H
J Cell Biochem; 2018 Jan; 119(1):17-27. PubMed ID: 28520219
[TBL] [Abstract][Full Text] [Related]
6. Skeletal muscle fibrosis: an overview.
Mahdy MAA
Cell Tissue Res; 2019 Mar; 375(3):575-588. PubMed ID: 30421315
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator inhibitor-1 in kidney pathology (Review).
Małgorzewicz S; Skrzypczak-Jankun E; Jankun J
Int J Mol Med; 2013 Mar; 31(3):503-10. PubMed ID: 23314920
[TBL] [Abstract][Full Text] [Related]
8. Impaired ECM Remodeling and Macrophage Activity Define Necrosis and Regeneration Following Damage in Aged Skeletal Muscle.
Rahman FA; Angus SA; Stokes K; Karpowicz P; Krause MP
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32605082
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation.
Kjøller L; Kanse SM; Kirkegaard T; Rodenburg KW; Rønne E; Goodman SL; Preissner KT; Ossowski L; Andreasen PA
Exp Cell Res; 1997 May; 232(2):420-9. PubMed ID: 9168821
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis.
Rerolle JP; Hertig A; Nguyen G; Sraer JD; Rondeau EP
Kidney Int; 2000 Nov; 58(5):1841-50. PubMed ID: 11044203
[TBL] [Abstract][Full Text] [Related]
11. Role of plasminogen activator inhibitor-1 in glucocorticoid-induced muscle change in mice.
Tamura Y; Kawao N; Shimoide T; Okada K; Matsuo O; Kaji H
J Bone Miner Metab; 2018 Mar; 36(2):148-156. PubMed ID: 28321652
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activator inhibitor-1 in tumor growth, angiogenesis and vascular remodeling.
Stefansson S; McMahon GA; Petitclerc E; Lawrence DA
Curr Pharm Des; 2003; 9(19):1545-64. PubMed ID: 12871067
[TBL] [Abstract][Full Text] [Related]
13. Altered interaction between plasminogen activator inhibitor type 1 activity and sympathetic nerve activity with aging.
Otowa K; Takamura M; Murai H; Maruyama M; Nakano M; Ikeda T; Kobayashi D; Ootsuji H; Okajima M; Furushou H; Yuasa T; Takata S; Kaneko S
Circ J; 2008 Mar; 72(3):458-62. PubMed ID: 18296846
[TBL] [Abstract][Full Text] [Related]
14. Critical role of plasminogen activator inhibitor-1 in cholestatic liver injury and fibrosis.
Bergheim I; Guo L; Davis MA; Duveau I; Arteel GE
J Pharmacol Exp Ther; 2006 Feb; 316(2):592-600. PubMed ID: 16221737
[TBL] [Abstract][Full Text] [Related]
15. Plasmin generation dependent on alpha-enolase-type plasminogen receptor is required for myogenesis.
López-Alemany R; Suelves M; Muñoz-Cánoves P
Thromb Haemost; 2003 Oct; 90(4):724-33. PubMed ID: 14515195
[TBL] [Abstract][Full Text] [Related]
16. The molecular basis for anti-proteolytic and non-proteolytic functions of plasminogen activator inhibitor type-1: roles of the reactive centre loop, the shutter region, the flexible joint region and the small serpin fragment.
Wind T; Hansen M; Jensen JK; Andreasen PA
Biol Chem; 2002 Jan; 383(1):21-36. PubMed ID: 11928815
[TBL] [Abstract][Full Text] [Related]
17. A novel antithrombotic role for high molecular weight kininogen as inhibitor of plasminogen activator inhibitor-1 function.
Chavakis T; Pixley RA; Isordia-Salas I; Colman RW; Preissner KT
J Biol Chem; 2002 Sep; 277(36):32677-82. PubMed ID: 12082110
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator inhibitor-1 and diabetic nephropathy.
Lee HB; Ha H
Nephrology (Carlton); 2005 Oct; 10 Suppl():S11-3. PubMed ID: 16174279
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor-1 in the pathogenesis of asthma.
Cho SH; Ryu CH; Oh CK
Exp Biol Med (Maywood); 2004 Feb; 229(2):138-46. PubMed ID: 14734792
[TBL] [Abstract][Full Text] [Related]
20. Growth factor-dependent proliferation and invasion of muscle satellite cells require the cell-associated fibrinolytic system.
Fibbi G; D'Alessio S; Pucci M; Cerletti M; Del Rosso M
Biol Chem; 2002 Jan; 383(1):127-36. PubMed ID: 11928807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
